A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

Also called NCT02460159

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 135 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02460159
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02460159. Non-randomized; no masking; primary purpose treatment. Start 2015-06-23 (actual); primary completion 2016-12-22 (actual). Results posted on 2018-01-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)
Condition
Hypercholesterolemia
Condition
Heterozygous Familial Hypercholesterolemia
Intervention (Drug)
EZ 10 mg/Atorva 20 mg FDC
Intervention (Drug)
EZ 10 mg/Atorva 10 mg FDC
Lead sponsor
Organon and Co (class: industry)

Record details

Record id
cardio:ct-nct02460159
Content hash
f4040c03e12ac7e86548fe6cf47f78a9d7b46d639af01b2abb941a5b16574fdb